Tel : +82 2 866 0604 Fax : +82 2 867 0125 Email : info@quratis.com
2022
~ 2020
Global phase 2b/3 IND approval for TB vaccine (Adolescents and adults)
Global vaccine leading technology center of the Ministry of Health and Welfare, Adjuvant nonclinical project
Emerging and Re-emerging Infectious Diseases mRNA vaccine project group, mRNA vaccine development nonclinical project
Technology evaluation passed
Vaccine Raw Material Equipment Win-Win Cooperation Council company by Korea Biotechnology Industry Organization
Signed a contract for joint development of tuberculosis vaccine with Shandong Lukang Hao Li You
QuaC inj (ascorbic acid) approved by Korea MFDS
Received KGMP certification for Osong Bio Plant
Korea Health Industry Development Institute, COVID-19 vaccine and raw & subsidiary material production facility equipment expansion support company
Korea-USA Global Vaccine Cooperation MOU with HDT Bio to produce mRNA COVID vaccine
Selected as a company for the mRNA Bio-venture Consortium and signed MOU
Ministry of Health and Welfare, COVID-19 vaccine & treatment new drug development clinical trial project
RIGHT Foundation, QTP105, schistosomiasis vaccine project
Selected as Development of schistosomiasis vaccine, QTP105 project supported by RIGHT Fund
Phase 1 IND approval for QTP104(COVID-19 vaccine) in South Korea
Phase 1 for adolescents of QTP101 completed & reported to MFDS
QTP101 for adolescents, Phase 1 CSR(Clinical Study Report) Completed & Reported to MFDS
Selected as the chamber of vaccine developers and manufacturing companies by Ministry of Health and Welfare
QTP101 for adults, Phase 2a CSR(Clinical Study Report) completed & Reported to MFDS
Phase 2a for adults of QTP101 completed & reported to MFDS
Signed an MOU with Hankook Korus pharm Co. Ltd for manufacture of the Russia's Covid-19 vaccine (Sputnik V)
Minister of SMEs and Startups, appointed as a SME for a human resource development
Minister’s Award by Ministry of Health and Welfare, Contribution to commercialization of health and medical technology
Minister’s Award by Ministry of Food and Drug Safety, Contribution to pharmaceutical industry development
Minister’s Award by Ministry of Employment and Labor, Good Job
QTP104, Co-development of COVID-19 Vaccine
Signed an MOU with the International Tuberculosis Research Center (ITRC) for research cooperation
Completion of Osong Bio Research Center and Bio Plant (GMP facility) Construction
Korea Institute for Advancement of Technology, KIAT 2020 BIG3 SMEs innovative growth support project
B&MGF RIGHT Foundation, Tuberculosis Vaccine project
Ministry of SMEs and Startups, Industry-Academic Collabo R&D project
Ministry of SMEs and Startups, Startup scale-up package project
Award by the Head of Korea Health Industry Development Institute (KHIDI)
Ministry of Health Welfare , Research-driven hospital promotion R&D project
2019
~ 2018
Grand Award for Biotechnology
Minister’s Award by Ministry of SMEs and Startups, Technology Innovation
Seoul Business Agency, Circovirus vaccine development project
Ministry of SMEs and Startups, Antibiotic-resistant antimicrobial agent project
Commencement of Osong plant construction
Osong Advanced Medical Complex, Formulation development project
Phase 1 IND approval for TB vaccine in adolescents
Safety pharmacology study project by KIT
Plant site purchase agreement in Osong
2017
~ 2016
Phase 2a IND approval for TB vaccine in adults
Execution of Exclusive License Agreement with Infectious Disease Research Institute (IDRI)
Hospital research project by MoHW
Establishment of a R&D Center
Establishment of Quratis Inc